ループス腎炎治療の世界市場:疫学予測

◆英語タイトル:Lupus Nephritis - Epidemiology Forecast To 2023
◆商品コード:DLVE704019
◆発行会社(リサーチ会社):DelveInsight
◆発行日:2017年3月
◆ページ数:73
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2営業日以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,750 ⇒換算¥305,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD5,500 ⇒換算¥610,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD8,250 ⇒換算¥915,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

DelveInsight’s “Lupus Nephritis – Epidemiology Forecast To 2023” Report provides an overview of the disease and global historical and forecasted epidemiological data for the prevalent, diagnosed and treatable cases of Lupus Nephritis from 2013-2023 for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and JapanLupus Nephritis is the most common kidney disorder caused by the life-threatening autoimmune disease such as Systemic Lupus Erythematosus (SLE). It is a leading cause of morbidity and mortality in patients with Systemic Lupus Erythematosus. It leads to inflammation of small blood vessels which play an important role in filtering waste materials in kidney. It also involves the inflammation of glomeruli. It is observed that approximately 50% to 60% of adults and 30% to 80% of children with lupus develop Lupus Nephritis. Frequency of developing Lupus Nephritis decreases after 5 years of Systemic Lupus Erythematosus.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Scope
- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2013-2023.
- The Report includes the Sex Specific and Age Specific Prevalence of Lupus Nephritis of 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan)

【レポートの目次】

Report Introduction
Lupus Nephritis: Overview
• Symptoms
• Pathophysiology
• Etiology
• Risk Factors
• Disease Burden
Unmet Needs
Epidemiology of Lupus Nephritis in 7MM
United States
Sex Specific Prevalence of Lupus Nephritis in United States
Age- Specific Prevalence of Lupus Nephritis in United States
EU5
• United Kingdom
Sex Specific Prevalence of Lupus Nephritis in UK
Age- Specific Prevalence of Lupus Nephritis in UK
• France
Sex Specific Prevalence of Lupus Nephritis in France
Age- Specific Prevalence of Lupus Nephritis in France
• Italy
Sex Specific Prevalence of Lupus Nephritis in Italy
Age- Specific Prevalence of Lupus Nephritis in Italy
• Spain
Sex Specific Prevalence of Lupus Nephritis in Spain
Age- Specific Prevalence of Lupus Nephritis in Spain
• Germany
Sex Specific Prevalence of Lupus Nephritis in Germany
Age- Specific Prevalence of Lupus Nephritis in Germany
Japan
Sex Specific Prevalence of Lupus Nephritis in Japan
Age- Specific Prevalence of Lupus Nephritis in Japan
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

Table 1: Prevalent Population of Lupus Nephritis in United States (2013-2023)
Table 2: Sex Specific Prevalence of Lupus Nephritis in United States (2013-2023)
Table 3: Age-Specific Prevalence of Lupus Nephritis in United States (2013-2023)
Table 4: Prevalent Population of Lupus Nephritis in United Kingdom (2013-2023)
Table 5: Sex Specific Prevalence of Lupus Nephritis in United Kingdom (2013-2023)
Table 6: Age-Specific Prevalence of Lupus Nephritis in United Kingdom (2013-2023)
Table 7: Prevalent Population of Lupus Nephritis in France (2013-2023)
Table 8: Sex Specific Prevalence of Lupus Nephritis in France (2013-2023)
Table 9: Age-Specific Prevalence of Lupus Nephritis in France (2013-2023)
Table 10: Prevalent Population of Lupus Nephritis in Italy (2013-2023)
Table 11: Sex Specific Prevalence of Lupus Nephritis in Italy (2013-2023)
Table 12: Age-Specific Prevalence of Lupus Nephritis in Italy (2013-2023)
Table 13: Prevalent Population of Lupus Nephritis in Spain (2013-2023)
Table 14: Sex Specific Prevalence of Lupus Nephritis in Spain (2013-2023)
Table 15: Age-Specific Prevalence of Lupus Nephritis in Spain (2013-2023)
Table 16: Prevalent Population of Lupus Nephritis in Germany (2013-2023)
Table 17: Sex Specific Prevalence of Lupus Nephritis in Germany (2013-2023)
Table 18:Age-Specific Prevalence of Lupus Nephritis in Germany (2013-2023)
Table 19: Prevalent Population of Lupus Nephritis in Japan (2013-2023)
Table 20: Sex Specific Prevalence of Lupus Nephritis in Japan (2013-2023)
Table 21:Age-Specific Prevalence of Lupus Nephritis in Japan (2013-2023)


Figure 1: Pathogenesis of Lupus Nephritis
Figure 2: Risk Factors of Lupus Nephritis
Figure 3: Prevalent Population of Lupus Nephritis in United States (2013-2023)
Figure 4: Sex Specific Prevalence of Lupus Nephritis in United States (2013-2023)
Figure 5: Age-Specific Prevalence of Lupus Nephritis in United States (2013-2023)
Figure 6: Prevalent Population of Lupus Nephritis in United Kingdom (2013-2023)
Figure 7: Sex Specific Prevalence of Lupus Nephritis in United Kingdom (2013-2023)
Figure 8: Age-Specific Prevalence of Lupus Nephritis in United Kingdom (2013-2023)
Figure 9: Prevalent Population of Lupus Nephritis in France (2013-2023)
Figure 10: Sex Specific Prevalence of Lupus Nephritis in France (2013-2023)
Figure 11: Age-Specific Prevalence of Lupus Nephritis in France (2013-2023)
Figure 12: Prevalent Population of Lupus Nephritis in Italy (2013-2023)
Figure 13: Sex Specific Prevalence of Lupus Nephritis in Italy (2013-2023)
Figure 14: Age-Specific Prevalence of Lupus Nephritis in Italy (2013-2023)
Figure 15: Prevalent Population of Lupus Nephritis in Spain (2013-2023)
Figure 16: Sex Specific Prevalence of Lupus Nephritis in Spain (2013-2023)
Figure 17: Age-Specific Prevalence of Lupus Nephritis in Spain (2013-2023)
Figure 18: Prevalent Population of Lupus Nephritis in Germany (2013-2023)
Figure 19: Sex Specific Prevalence of Lupus Nephritis in Germany (2013-2023)
Figure 20:Age-Specific Prevalence of Lupus Nephritis in Germany (2013-2023)
Figure 21: Prevalent Population of Lupus Nephritis in Japan (2013-2023)
Figure 22: Sex Specific Prevalence of Lupus Nephritis in Japan (2013-2023)
Figure 23:Age-Specific Prevalence of Lupus Nephritis in Japan (2013-2023)


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ループス腎炎治療の世界市場:疫学予測(Lupus Nephritis - Epidemiology Forecast To 2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆